Advancements at Mayo Clinic – Hepatitis C is no longer a barrier to transplant April 28, 2022 Overview Show transcript Overview Bashar A. Aqel, M.D., a transplant hepatologist at Mayo Clinic in Arizona, discusses ways to expand the potential donor pool and shorten the wait time to transplant for patients with end-stage liver disease. Mayo Clinic transplant hepatologists and surgeons led a multisite, prospective observational study of liver transplant using allografts from donors with hepatitis C virus for recipients who are HCV-seronegative. Outcomes proved positive and our transplant experts have now expanded these protocols for other organs such as the kidney and heart. Learn more about how hepatitis C organs are now usable for transplant Refer a patient Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related Content Q and AUnderstanding HCV and evolving treatment guidelinesArticleHepatitis C livers now usable for transplant into patients uninfected with hepatitis C VID-20535098 Medical Professionals Advancements at Mayo Clinic – Hepatitis C is no longer a barrier to transplant